Search

everythinglearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Finasteride raises suicide-linked aggression and stops clozapine's positive effects in schizophrenia animals.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

ACBP is essential for healthy skin and fur by maintaining the skin's barrier function.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Biochanin A promotes hair growth in mice with testosterone-induced hair loss.

Cucurbitacin helps mice grow hair by blocking a protein that stops hair growth.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Biosimilars lower costs but don't significantly improve access.

Tribulus terrestris may protect the liver from drug damage.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.